Ole Helm

1.0k total citations
21 papers, 804 citations indexed

About

Ole Helm is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ole Helm has authored 21 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Ole Helm's work include Pancreatic and Hepatic Oncology Research (12 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Pancreatitis Pathology and Treatment (4 papers). Ole Helm is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Genomics, phytochemicals, and oxidative stress (4 papers) and Pancreatitis Pathology and Treatment (4 papers). Ole Helm collaborates with scholars based in Germany, United States and Austria. Ole Helm's co-authors include Susanne Sebens, H. Schäfer, Christoph Röcken, Janka Held‐Feindt, Hendrik Ungefroren, Bence Sipos, Dieter Kabelitz, Evelin Grage‐Griebenow, Michael Ebsen and Ilka Vogel and has published in prestigious journals such as PLoS ONE, Oncogene and Journal of Cell Science.

In The Last Decade

Ole Helm

21 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ole Helm Germany 14 409 360 334 174 86 21 804
Wataru Sakamoto Japan 19 396 1.0× 393 1.1× 279 0.8× 152 0.9× 95 1.1× 65 837
Jiachi Ma China 13 343 0.8× 396 1.1× 159 0.5× 221 1.3× 77 0.9× 28 747
Hao‐Chen Wang Taiwan 15 342 0.8× 420 1.2× 253 0.8× 190 1.1× 92 1.1× 30 934
Qihao Ren United States 8 247 0.6× 457 1.3× 259 0.8× 129 0.7× 30 0.3× 12 875
Manuela Liguori Italy 8 317 0.8× 283 0.8× 394 1.2× 100 0.6× 25 0.3× 10 706
Keitaro Kanda Japan 6 398 1.0× 235 0.7× 237 0.7× 125 0.7× 94 1.1× 9 686
Justine Bellier Belgium 11 211 0.5× 270 0.8× 130 0.4× 159 0.9× 43 0.5× 11 632
Xinyun Xu China 11 183 0.4× 266 0.7× 199 0.6× 182 1.0× 40 0.5× 24 572
Xiaobin Lin China 8 508 1.2× 502 1.4× 477 1.4× 328 1.9× 73 0.8× 16 1.1k
Beatriz Soldevilla Spain 15 389 1.0× 523 1.5× 200 0.6× 295 1.7× 52 0.6× 25 918

Countries citing papers authored by Ole Helm

Since Specialization
Citations

This map shows the geographic impact of Ole Helm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Helm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Helm more than expected).

Fields of papers citing papers by Ole Helm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Helm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Helm. The network helps show where Ole Helm may publish in the future.

Co-authorship network of co-authors of Ole Helm

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Helm. A scholar is included among the top collaborators of Ole Helm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Helm. Ole Helm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scharfenberg, Franka, Florian Peters, Ole Helm, et al.. (2021). Characterization of the Cancer-Associated Meprin Βeta Variants G45R and G89R. Frontiers in Molecular Biosciences. 8. 702341–702341. 4 indexed citations
2.
Rahn, Sascha, Marcus Lettau, Ole Helm, et al.. (2020). Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses. PLoS ONE. 15(9). e0239369–e0239369. 25 indexed citations
3.
Rahn, Sascha, Sandra Krüger, Lisa Goebel, et al.. (2019). POLE Score: a comprehensive profiling of programmed death 1 ligand 1 expression in pancreatic ductal adenocarcinoma. Oncotarget. 10(16). 1572–1588. 18 indexed citations
4.
5.
Hauser, Charlotte A. E., Ole Helm, Jan-Hendrik Egberts, et al.. (2019). The Hepatic Microenvironment and TRAIL-R2 Impact Outgrowth of Liver Metastases in Pancreatic Cancer after Surgical Resection. Cancers. 11(6). 745–745. 13 indexed citations
6.
Li, Wenjia, Ole Helm, Sandra Krüger, et al.. (2019). The cancer-associated meprin β variant G32R provides an additional activation site and promotes cancer cell invasion. Journal of Cell Science. 132(11). 11 indexed citations
9.
Lenk, Lennart, Maren Pein, Olga Will, et al.. (2017). The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma. OncoImmunology. 7(1). e1368603–e1368603. 35 indexed citations
10.
Rahn, Sascha, Kerstin Stemmer, Lennart Lenk, et al.. (2017). Diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells. Cancer Letters. 415. 129–150. 90 indexed citations
11.
Schumacher, Neele, Florian Peters, Johannes Prox, et al.. (2017). Cancer-associated mutations in the canonical cleavage site do not influence CD99 shedding by the metalloprotease meprin β but alter cell migration in vitro. Oncotarget. 8(33). 54873–54888. 13 indexed citations
12.
Ungefroren, Hendrik, Ole Helm, Sebastian Hübner, et al.. (2016). Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1. Cellular Signalling. 28(11). 1652–1662. 11 indexed citations
14.
Goebel, Lisa, Evelin Grage‐Griebenow, Ole Helm, et al.. (2015). CD4+T cells potently induce epithelial-mesenchymal-transition in premalignant and malignant pancreatic ductal epithelial cells–novel implications of CD4+T cells in pancreatic cancer development. OncoImmunology. 4(4). e1000083–e1000083. 41 indexed citations
15.
Helm, Ole, et al.. (2015). The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells. PLoS ONE. 10(7). e0132978–e0132978. 52 indexed citations
16.
Helm, Ole, Janka Held‐Feindt, H. Schäfer, & Susanne Sebens. (2014). M1 and M2: there is no “good” and “bad”—How macrophages promote malignancy-associated features in tumorigenesis. OncoImmunology. 3(7). e946818–e946818. 33 indexed citations
17.
Hattermann, Kirsten, Susanne Sebens, Ole Helm, et al.. (2014). Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia. Oncology Reports. 32(1). 270–276. 56 indexed citations
18.
Helm, Ole, Janka Held‐Feindt, Evelin Grage‐Griebenow, et al.. (2014). Tumor‐associated macrophages exhibit pro‐ and anti‐inflammatory properties by which they impact on pancreatic tumorigenesis. International Journal of Cancer. 135(4). 843–861. 214 indexed citations
19.
Helm, Ole, Lisa Goebel, Sandra Freitag‐Wolf, et al.. (2014). Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma. PLoS ONE. 9(5). e94357–e94357. 61 indexed citations
20.
Ungefroren, Hendrik, Susanne Sebens, Klaudia Giehl, et al.. (2013). Rac1b negatively regulates TGF-β1-induced cell motility in pancreatic ductal epithelial cells by suppressing Smad signalling. Oncotarget. 5(1). 277–290. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026